Viking Global Investors and General Atlantic have led a $80m round for Switzerland-based Pharvaris, a company that is developing therapies for the treatment of hereditary angioedema (HAE).
Deal is Recover's 23rd acquisition since it was established six years ago, and the third since being acquired by EQT
Gimv formed the climate control business in 2016 by merging Itho Daalderop and Klimaatgarant
Corporate venture arm Shell Ventures leads the round for the IoT energy systems software platform
GP invests in the company via Wisequity V, which closed on its €260m hard-cap in July 2019